i FDA / Compounded-drug disclosure
Clinical efficacy figures referenced on this page (SURMOUNT-1, STEP-1, and other trials) were generated with FDA-approved branded products. OPTML dispenses compounded preparations of semaglutide, tirzepatide, testosterone, and related molecules via licensed 503A pharmacies under U.S. physician prescription. Compounded preparations are not FDA-approved. Individual results vary.
60-second personalized match

Find your optimal protocol, in 6 questions.

Built by physicians, not algorithms. Tells you the exact OPTML protocol that fits your goals, with cost, lab needs, and timeline.

Question 1 of 6 ~60 seconds
Live AI · Physician-trained

Ask the OPTML assistant anything.

Real answers, cited from our physician content.

OPTML Assistant
Curated FAQ assistant · pre-written answers · not a clinical channel

Curated educational assistant. Not medical advice. The OPTML Assistant matches your question to a library of pre-written responses authored and reviewed by the OPTML team. It does not use a generative language model, does not access patient data, and does not generate medical recommendations, dosing, diagnosis, or treatment. All clinical decisions are made by licensed U.S. physicians within the Telegra MD network after individual evaluation. For urgent medical issues call 911 or your provider. Talk to a person →

Type a question, or tap a chip to get started.
Educational purposes only. The Find My Protocol provides educational estimates based on published clinical formulas and peer-reviewed research. It is not medical advice, does not constitute a prescription, and is not a substitute for evaluation by a licensed clinician. All medical decisions, including any treatment, medication, or dosing recommendations, are made exclusively by a U.S. licensed physician after individual patient evaluation through OPTML's intake process.
Methodology & Sources Click here for the formulas, datasets, and peer-reviewed studies behind this tool View details ↓Hide ↑

How this tool calculates

The "Find My Protocol" quiz is an educational routing tool that asks about your goals, symptoms, and health history, then suggests which OPTML treatment categories may be relevant for discussion with a licensed provider. It does not diagnose, prescribe, or recommend specific medications or doses. All treatment decisions are made by a U.S. licensed physician after individual evaluation during the intake process.

Peer-reviewed sources

  1. 1.Bhasin S, Brito JP, Cunningham GR, et al. Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2018;103(5):1715-1744.
  2. 2.The 2022 Hormone Therapy Position Statement of The North American Menopause Society. Menopause. 2022;29(7):767-794.
  3. 3.Wilding JPH, Batterham RL, Calanna S, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med. 2021;384(11):989-1002.
  4. 4.Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide Once Weekly for the Treatment of Obesity. N Engl J Med. 2022;387(3):205-216.

Important. This tool is provided for educational purposes only and does not constitute medical advice, diagnosis, or treatment. The tool does not prescribe medication, recommend specific dosing, or substitute for clinical evaluation. Compounded medications referenced anywhere on this site are not FDA-approved; the FDA does not verify the safety, effectiveness, or quality of compounded drugs. Treatment decisions are made only by a licensed U.S. physician after individual patient evaluation.